日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/11/14 | 1,768 | 1,794 | 1,755 | 1,785 | +6 | +0.3% | 239,000 |
| 2013/11/13 | 1,775 | 1,793 | 1,771 | 1,779 | +11 | +0.6% | 253,000 |
| 2013/11/12 | 1,743 | 1,772 | 1,739 | 1,768 | +31 | +1.8% | 316,000 |
| 2013/11/11 | 1,729 | 1,744 | 1,721 | 1,737 | +17 | +1% | 183,000 |
| 2013/11/08 | 1,680 | 1,724 | 1,672 | 1,720 | +66 | +4% | 259,000 |
| 2013/11/07 | 1,636 | 1,663 | 1,634 | 1,654 | +20 | +1.2% | 141,000 |
| 2013/11/06 | 1,615 | 1,664 | 1,615 | 1,634 | -1 | -0.1% | 119,000 |
| 2013/11/05 | 1,689 | 1,689 | 1,625 | 1,635 | -18 | -1.1% | 234,000 |
| 2013/11/01 | 1,690 | 1,690 | 1,644 | 1,653 | -37 | -2.2% | 111,000 |
| 2013/10/31 | 1,691 | 1,708 | 1,688 | 1,690 | ±0 | ±0% | 156,000 |
| 2013/10/30 | 1,706 | 1,718 | 1,687 | 1,690 | -15 | -0.9% | 279,000 |
| 2013/10/29 | 1,697 | 1,713 | 1,676 | 1,705 | +18 | +1.1% | 264,000 |
| 2013/10/28 | 1,675 | 1,696 | 1,674 | 1,687 | +14 | +0.8% | 138,000 |
| 2013/10/25 | 1,710 | 1,710 | 1,670 | 1,673 | -42 | -2.4% | 160,000 |
| 2013/10/24 | 1,693 | 1,720 | 1,680 | 1,715 | +27 | +1.6% | 135,000 |
| 2013/10/23 | 1,718 | 1,722 | 1,686 | 1,688 | -19 | -1.1% | 132,000 |
| 2013/10/22 | 1,709 | 1,715 | 1,700 | 1,707 | -7 | -0.4% | 118,000 |
| 2013/10/21 | 1,710 | 1,720 | 1,700 | 1,714 | +21 | +1.2% | 206,000 |
| 2013/10/18 | 1,677 | 1,696 | 1,671 | 1,693 | +17 | +1% | 113,000 |
| 2013/10/17 | 1,679 | 1,690 | 1,667 | 1,676 | +4 | +0.2% | 98,000 |
| 2013/10/16 | 1,663 | 1,680 | 1,662 | 1,672 | +4 | +0.2% | 108,000 |
| 2013/10/15 | 1,676 | 1,688 | 1,656 | 1,668 | -7 | -0.4% | 299,000 |
| 2013/10/11 | 1,680 | 1,680 | 1,665 | 1,675 | +28 | +1.7% | 182,000 |
| 2013/10/10 | 1,636 | 1,660 | 1,634 | 1,647 | +16 | +1% | 167,000 |
| 2013/10/09 | 1,616 | 1,637 | 1,600 | 1,631 | +20 | +1.2% | 178,000 |
| 2013/10/08 | 1,604 | 1,628 | 1,587 | 1,611 | +9 | +0.6% | 169,000 |
| 2013/10/07 | 1,616 | 1,623 | 1,592 | 1,602 | -15 | -0.9% | 176,000 |
| 2013/10/04 | 1,623 | 1,654 | 1,608 | 1,617 | -8 | -0.5% | 165,000 |
| 2013/10/03 | 1,622 | 1,658 | 1,622 | 1,625 | -24 | -1.5% | 227,000 |
| 2013/10/02 | 1,715 | 1,717 | 1,641 | 1,649 | -60 | -3.5% | 294,000 |
| 2013/10/01 | 1,713 | 1,717 | 1,703 | 1,709 | +17 | +1% | 224,000 |
| 2013/09/30 | 1,728 | 1,728 | 1,689 | 1,692 | -60 | -3.4% | 243,000 |
| 2013/09/27 | 1,733 | 1,782 | 1,731 | 1,752 | +30 | +1.7% | 123,000 |
| 2013/09/26 | 1,726 | 1,755 | 1,632 | 1,722 | -44 | -2.5% | 242,000 |
| 2013/09/25 | 1,756 | 1,789 | 1,748 | 1,766 | -29 | -1.6% | 106,000 |
| 2013/09/24 | 1,785 | 1,803 | 1,738 | 1,795 | +3 | +0.2% | 290,000 |
| 2013/09/20 | 1,771 | 1,798 | 1,771 | 1,792 | +21 | +1.2% | 147,000 |
| 2013/09/19 | 1,725 | 1,772 | 1,725 | 1,771 | +46 | +2.7% | 100,000 |
| 2013/09/18 | 1,754 | 1,774 | 1,702 | 1,725 | -44 | -2.5% | 399,000 |
| 2013/09/17 | 1,758 | 1,785 | 1,753 | 1,769 | +16 | +0.9% | 174,000 |
| 2013/09/13 | 1,750 | 1,764 | 1,719 | 1,753 | +6 | +0.3% | 218,000 |
| 2013/09/12 | 1,697 | 1,753 | 1,683 | 1,747 | +59 | +3.5% | 221,000 |
| 2013/09/11 | 1,713 | 1,724 | 1,684 | 1,688 | -32 | -1.9% | 105,000 |
| 2013/09/10 | 1,712 | 1,738 | 1,689 | 1,720 | +4 | +0.2% | 138,000 |
| 2013/09/09 | 1,670 | 1,728 | 1,670 | 1,716 | +61 | +3.7% | 148,000 |
| 2013/09/06 | 1,678 | 1,680 | 1,616 | 1,655 | -5 | -0.3% | 124,000 |
| 2013/09/05 | 1,692 | 1,692 | 1,655 | 1,660 | -32 | -1.9% | 58,000 |
| 2013/09/04 | 1,665 | 1,705 | 1,660 | 1,692 | -6 | -0.4% | 136,000 |
| 2013/09/03 | 1,650 | 1,700 | 1,650 | 1,698 | +72 | +4.4% | 100,000 |
| 2013/09/02 | 1,604 | 1,641 | 1,604 | 1,626 | -1 | -0.1% | 91,000 |
2801～
2850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
